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INTRODUCTION
C
hronic obstructive pulmonary disease (COPD)
affects 210 million people worldwide. It is pro-
jected to be the seventh leading cause of years
lived with disability by 2030.1-2 In Portugal, the
prevalence of COPD is 14.2% in the population above
45 years of age. It is estimated that 800,000 citizens live
with COPD.3 COPD is characterised by persistent limi-
tation of airflow that is usually progressive. Exacerba-
tions and comorbidities can cause a highly incapaci-
tating disease.4
Rev Port Med Geral Fam 2015;31:24-32
24
Cristina Jácome, MSc,* Alda Marques, PhD,** Raquel Gabriel, MSc,*** Joana Cruz, MSc,**** Daniela Figueiredo, PhD*****
Anxiety and depression in
Portuguese patients with
chronic obstructive pulmonary
disease: a multicentre 
cross-sectional study
ABSTRACT
Objectives:To assess symptoms of anxiety and depression among Portuguese patients with chronic obstructive pulmonary di-
sease (COPD) and associated predictive factors.
Study design: A multicentre, cross-sectional study.
Setting: Three primary care centres and one district hospital in the central region of Portugal.
Participants: 302 Portuguese outpatients with COPD.
Methods: Symptoms of anxiety and depression were assessed with the Hospital Anxiety and Depression Scale (HADS). Scores
≥8 were considered clinically significant.
Results: This sample of patients had a mean age of 67±12 years and 41% were female. COPD was graded as mild in 106 (35.1%),
moderate in 106 (35.1%) and severe-to-very-severe 90 patients (29.8%). Clinically significant anxiety was found in 53.3% of
patients and symptoms of depression in 45.4%. Symptoms of anxiety were associated with limitation of activities (OR 1.39,
95% CI 1.04-1.84), age (0.97, 95% CI 0.94-0.99) and female gender (OR 0.37; 95% CI 0.20-0.66). Symptoms of depression were
associated with functional mobility (OR 1.91, 95% CI 1.38-2.66) and limitation of activities (OR 1.12, 95% CI 1.04-1.21).
Conclusions: A high proportion of Portuguese patients with COPD experience symptoms of anxiety and depression. National
pulmonary rehabilitation programmes might need to include collaborative self-management interventions to address patients’
emotional needs.
Keywords: Chronic Obstructive Pulmonary Disease; Anxiety; Depression.
Anxiety and depression are common symptoms in
patients with COPD. This may have a detrimental effect
on quality of life and well-being as these symptoms can
affect emotional, social and physical functioning.5
There is a complex interaction between anxiety and
breathlessness that often exists as a vicious cycle of
worsening symptoms.6
In studies conducted in the United Kingdom, Den-
mark, Canada and New Zealand, 50%to 74%of patients
with COPD presented symptoms of anxiety and 28% to
80% symptoms of depression.7-10 In recent systematic
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reviews, lower prevalences have been reported, with
10-55%11 of patients showing symptoms of anxiety and
7-46%12 depression. In Portugal, the prevalence of
symptoms of anxiety and depression in patients with
COPD is unknown. One retrospective study, of the im-
pact of comorbidities in outcomes of respiratory reha-
bilitation, reported that 21.1% (n=24) of patients with
COPD had anxiety or depression.13
The current study aimed to assess symptoms of anx-
iety and depression among Portuguese patients with
COPD and to identify associated factors.
METHODS
Study design
A multicentre, cross-sectional study of Portuguese
outpatients with COPD was conducted in the central re-
gion of Portugal between December 2010 and Decem-
ber 2012. The study received Institutional Ethics Com-
mittee approval. The reporting of this study conforms
to the STROBE statement.14
Participants
The sample was recruited from three primary care
centres and one district hospital. The clinicians of these
institutions identified patients for the study. They en-
sured that patients met the criteria for eligibility. Inclu-
sion criteria included a diagnosis of COPD according to
the Global Initiative for Chronic Obstructive Lung Dis-
ease (GOLD) criteria,4 age  ≥ 18 years old, the ability to
understand the purpose of the study and to give vo-
luntarily consent to participate. Exclusion criteria were
the presence of severe psychiatric conditions or the in-
ability to understand and co-operate.
Eligible patients were contacted by telephone. The
researchers explained the purpose of the study and
asked about their willingness to participate. If they
agreed to participate, an appointment was scheduled
at the patient’s primary care clinic or hospital. Before
data collection, more detailed information about the
study was provided to the patient and written informed
consent was obtained.
Data collection procedures
Socio-demographic data (age, gender, educational
level, marital status and occupation) and clinical data
(body mass index [BMI], comorbidities, medication)
were recorded first. Lung function and functional mo-
bility were then assessed. Lastly, limitation of activities
resulting from breathlessness and symptoms of anxiety
and depression were assessed.
Measures
Lung function
Spirometry, using a portable spirometer (MicroLab
3500, CareFusion, Kent, UK), was performed according
to the American Thoracic Society/European Respirato-
ry Society Task Force standards for lung function tes-
ting.15The classification of the severity COPD was made
in accordance with the GOLD criteria.4
Functional mobility
The Timed Up and Go (TUG) test was used as a test
of functional mobility. This test is often used in patients
with COPD.16-17 It requires the patient to rise from a stan-
dard chair, walk 3 meters, turn around, walk back to the
chair, and sit down, after the command “go”.18 Patients
were instructed to walk quickly, but as safely as possi-
ble. Two TUG tests were performed and the best per-
formance was considered.
Limitation of activities resulting from breathlessness
The Modified British Medical Research Council ques-
tionnaire (mMRC) was used to assess symptoms in pa-
tients with COPD, as recommended by GOLD.4Patients re-
ported their limitation of activities resulting from breath-
lessness by selecting the statement that best described
their limitation.19The questionnaire comprises five grades
(statements) on a scale from 0 to 4, with higher grades in-
dicating greater perceived respiratory limitation. 
Symptoms of anxiety and depression 
The Portuguese version of the Hospital Anxiety and
Depression Scale (HADS) was used to assess symptoms
of anxiety and depression.20 This scale has been widely
used in patients with COPD and has been reported in-
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ternationally as a valid and reliable instrument.21 The
HADS contains 14 items. Seven items measure symp-
toms of anxiety (HADS-A) and 7 symptoms of depres-
sion (HADS-D).22 The presence of clinically significant
symptoms of anxiety or depression was defined by a
HADS-A/HADS-D score of ≥ 8.21 The severity of symp-
toms of anxiety or depression was categorised as mild
(score 8-10), moderate (score 11-14) or severe (score
15-21).20 Coefficients of Cronbach’s alpha found in the
present study (0.78 for anxiety and 0.74 for depression)
were similar to those reported by Pais-Ribeiro et al (0.76
and 0.81, respectively).20
Statistical analysis
Descriptive statistics were used to describe the socio-
demographic variables, clinical characteristics, and the
HADS-A/HADS-D scores. As most of the previous stu-
dies of symptoms of anxiety and depression in COPD
used “point prevalence”, the frequency of symptoms of
anxiety and depression (HADS-A/HADS-D≥8) was
computed based on this estimation. This facilitated the
discussion of results. Frequencies were presented to-
gether with the 95% confidence intervals. The severity
of symptoms of anxiety and depression was categorised
as ‘mild’ (HADS-A/HADS-D ≥8 and ≤10), ‘moderate’
(HADS-A/HADS-D ≥11 and ≤14) or ‘severe’ (HADS-
A/HADS-D ≥15 and ≤21).20 To explore associations be-
tween variables related to the presence of clinically sig-
nificant symptoms of anxiety and depression, variables
of patients with and without symptoms of anxiety and
depression (HADS-A/HADS-D≥8 compared to HADS-
A/HADS-D<8) were compared using independent t-
-tests for normally distributed data, Mann-Whitney U-
tests for non-normally distributed data and ordinal
data, and Chi-square tests for categorical data. In the
case of chi-square tests, when a statistically significant
difference was found for a categorical variable with
more than two categories, chi-square multiple com-
parison tests with Bonferroni correction were per-
formed to explore which categories differed from each
other. The variables that were statistically different
(p<0.05) between the two groups were used to further
explore their relationship with the severity of anxiety
and depression and to perform two multivariate logis-
tic regressions (Enter method). The dependent variable
in each multivariate logistic regression was the presence
of clinically significant symptoms of anxiety symptoms
or depression (0 = absent, 1 = present). Multiple logis-
tic regression analysis was used for predictive purpo-
ses and to adjust for possible confounders.23 The level
of significance considered was 0.05. Statistical analyses
were performed using IBM SPSS Statistics version 20.0
(IBM Corporation, Armonk, NY, USA).
RESULTS
Characteristics of participants 
The total number of patients initially screened at the
Characteristics
Age (years) M±SD 67 ± 12
Female n(%) 124 (41.1)
Educational level n(%)
No education completed 32 (10.6)
Primary school 156 (51.6)
Secondary school 83 (27.5)
High school/University 31 (10.3)
Marital status, n(%)
Married/Living as a couple 210 (69.5)
Widowed 52 (17.2)
Single 18 (6)
Separated/divorced 22 (7.3)
Current occupation n(%)
Retired 220 (72.8)
Employed 58 (19.2)
Unemployed 24 (8)
BMI (kg/m2) M±SD 27.8 ± 5.6
mMRC Md[IQR] 2 [1, 3]
FEV
1
% predicted M±SD 62.4 ± 22.6
GOLD Classification n(%)
Mild 106 (35.1)
Moderate 106 (35.1)
Severe-to-very-severe 90 (29.8)
TABLE I. Socio-demographic and clinical characteristics
of the participants (n=302)
Abbreviations: BMI=body mass index; FEV
1
=forced expiratory volume in
1 second; GOLD=Global Initiative for Chronic Obstructive Lung Disease;
IQR=interquartile range; M=mean; Md=median; mMRC=Modified British
Medical Research Council questionnaire.
participating institutions was not possible to obtain
due to the recruitment strategy. A total of 340 patients
with COPD were approached by the research team for
inclusion in the study, however 32 refused to participate
due to personal reasons and 6 failed to attend the ar-
ranged meeting. The final sample comprised 302 pa-
tients with COPD (mean age 67±12 years old; 41.1% fe-
male). The majority of participants had completed pri-
mary school (n=156; 51.6%) and were retired (n=220;
72.8%). The mean BMI was 27.8±5.6kg/m2 and the me-
dian mMRC grade was 2 (‘I walk slower than people of
the same age on the level because of the breathless-
ness’, or ‘I have to stop for breath when walking on my
own pace on the level’). According to the GOLD crite-
ria, 106 (35.1%) patients had mild, 106 (35.1%) mode-
rate and 90 (29.8%) had severe-to-very-severe COPD.
Table I shows the socio-demographic and clinical cha-
racteristics of the study participants.
Symptoms of anxiety and depression 
The mean anxiety score was 8.1±4.4 and the mean
depression score was 7.3±4. A total of 161 (53.3%; 95%
CI 48-58.9)patients had clinically significant symptoms
of anxiety. Symptoms of anxiety were experienced
mainly as ‘mild’ (n=74; 46%, 95%CI 38.5-53.4) or ‘mode-
rate’ (n=59; 36.6%, 95% CI 29.2-44.7) with few ‘severe’
cases (n=28; 17.4%, 95%CI 11.8-23.6). Clinically signif-
icant symptoms of depression were present in 45.4%
(95%CI 40.1-50.7, n=137) of patients. These symptoms
were experienced as ‘mild’ in the majority of the sam-
ple (n=74; 54%, 95% CI 46-62.8), but also ‘moderate’
(n=48; 35%, 95% CI 27-43.1) and a few ‘severe’ cases
were found (n=15; 11%, 95% CI 5.8-16.1). A total of 99
(32.8%, 95%CI 27.5-38.1) patients had both symptoms
of anxiety and depression.
Associations between anxiety and depression and
socio-demographic characteristics
Symptoms of anxiety and depression were more fre-
quent in female patients (p<0.001 and p=0.044) (table
II). Symptoms of anxiety were also more frequent in
younger patients (p=0.008) and unemployed patients
(p=0.002). Symptoms of depression were more frequent
in those with lower educational levels (no education
completed, primary school and secondary school;
p<0.001) (table II). Regarding the association of gender
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and severity of anxiety, it was found that the frequency
of females with moderate and severe anxiety (66.1%
and 67.9%, respectively) was significantly higher than
females with mild anxiety (33.8%, p<0.001). No other
statistically significant differences were found.
Relationship between symptoms of anxiety and 
depression and clinical characteristics 
The frequency of symptoms of anxiety and depres-
sion was higher in patients with greater limitation of ac-
tivities resulting from breathlessness (mMRC, p=0.043
and p<0.001) (table III). The frequency of symptoms of
depression was also higher in patients with higher me-
dication intake (p=0.002), advanced COPD (p=0.036)
and lower functional mobility (p<0.001) (table III). Lim-
itation of activities resulting from breathlessness was
higher in patients with moderate or severe anxiety (Me-
dian 2, Interquartile range [1,3]; 2[2,3]) and depression
(3[2,3]; 3[1.5,3]) than in those with mild anxiety (2[1,2],
p=0.026) and depression (2[1,3], p=0.016). No other sta-
tistically significant differences were observed regar-
ding the severity of symptoms.
Predictors of anxiety and depression 
Two multivariate logistic regressions were performed
to identify the predictors of symptoms of anxiety and
depression. Symptoms of anxiety were predicted by 
limitation of activities resulting from breathlessness
(OR 1.39, 95%CI 1.04-1.84), age (0.97, 95%CI 0.94-0.99),
and female gender (OR 0.37; 95% CI 0.20-0.66). Symp-
toms of depression were predicted by functional mo-
bility (OR 1.91, 95% CI 1.38-2.66) and limitation of ac-
tivities (OR 1.12, 95% CI 1.04-1.21). These logistic re-
gression models predicted 13% of the total variance of
anxiety and 22.4% of the total variance of symptoms of
depression.
DISCUSSION
This study showed that a large proportion of Por-
tuguese patients with COPD present symptoms of an-
xiety and depression. Limitation of activities resulting
from breathlessness, female gender, age and function-
al mobility were predictors of these distressing symp-
toms.
More than half of patients had symptoms of anxiety
(53.3%) and 45.4% had symptoms of depression. This
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Characteristics Not anxious Anxious p-value Not depressed Depressed p-value
(n=141) (n=161) (n=165) (n=137)
Age (years) M±SD 68.9±12.4 65.2±11.5 0.008* 65.9±12.5 68.3±11.3 0.084*
Gender n(%)
Female 41 (29.1) 83 (51.6) <0.001† 60 (36.4) 64 (46.7) 0.044†
Male 100 (70.9) 78 (48.4) 105 (63.6) 73 (53.3)
Educational level n(%)
No education completed 12 (8.5) 20(12.4) 0.055† 13 (7.9) 19 (13.9) <0.001†
Primary school 66 (46.8) 90(55.9) 73 (44.2) 83 (60.6)
Secondary school 41 (29.1) 42(26.1) 55 (33.3) 28 (20.4)
High school/University 22 (15.6) 9(5.6) 24 (14.6) 7 (5.1)
Marital status, n (%)
Married/Living as a couple 104 (73.7) 106(65.8) 0.086† 114(69.1) 96 (70.1) 0.099†
Widowed 17 (12.1) 35(21.8) 23 (13.9) 29 (21.2)
Single 11 (7.8) 7(4.3) 12 (7.3) 6 (4.4)
Separated/divorced 9 (6.4) 13(8.1) 16 (9.7) 6 (4.4)
Current occupation n(%)
Retired 109 (77.3) 111 (69) 0.002† 115 (69.7) 105 (76.6) 0.083†
Employed 29 (20.6) 29 (18) 39 (23.6) 19 (13.9)
Unemployed 3 (2.1) 21 (13) 11 (6.7) 13 (9.5)
TABLE II. Socio-demographic characteristics of patients with and without symptoms of anxiety and depression
*, independent t-tests; †, Chi-square tests.
Characteristics Not anxious Anxious p-value Not depressed Depressed p-value
(n=141) (n=161) (n=165) (n=137)
Comorbidities Md[IQR] 2[1, 3] 2[1, 3] 0.655‡ 2[1, 2] 2[1, 3] 0.075‡
Medications Md[IQR] 3[2, 5] 4 [2, 6] 0.091‡ 3[2, 5] 4[2.75, 6] 0.002‡
GOLD Classification n(%)
Mild 51 (36.2) 55 (34.2) 0.053† 68 (41.2) 38 (27.7) 0.036†
Moderate 43 (30.5) 63 (39.1) 56 (33.9) 50 (36.5)
Severe/Very severe 47 (33.3) 43 (26.7) 41 (24.9) 49 (35.8)
mMRC Md[IQR] 2[1, 2] 2[1, 3] 0.043‡ 1.5[1, 2] 2[1, 3] <0.001‡
Functional mobility M±SD 10.1±5.8 10.6±4.2 0.451* 9.2±3.9 11.8±5.8 <0.001*
TABLE III. Clinical characteristics of patients with and without symptoms of anxiety and depression
*, independent t-tests; ‡, Chi-square tests; †, Mann-Whitney U-tests. Abbreviations: IQR=interquartile range; M=mean; Md=median; mMRC=Modified
British Medical Research Council questionnaire.
is higher than the value reported by Carreiro (21.1%).13
The proportions found in the present study fall within
the range of estimates found among patients with
COPD in other countries.7-12 Comparisons need to be in-
terpreted with caution as different instruments were
used in other studies.
The presence of symptoms of both anxiety and de-
pression was predicted by limitation of activities re-
sulting from breathlessness. The severity of anxiety and
depression was also related to the severity of breath-
lessness. Respiratory symptoms have been associated
with patients’ anxiety and depression.8 The frequency
of symptoms of anxiety was similar in early and ad-
vanced COPD. The results strengthen previous findings
stating that even at earlier stages of the disease, the un-
certain and unpredictable nature of the symptoms and
acute exacerbations have an impact of on patients’
emotional well-being.24
Anxiety was also predicted by female gender and age.
Female gender was related to higher emotional distress,
consistent with previously published results.25-26 This
may reflect the gender differences already found in the
general population.27 A higher frequency of symptoms
of anxiety was found in younger and unemployed pa-
tients, which has been found previously.25-26,28 These
findings are relevant for clinical practice. It can be hy-
pothesised that older patients interpret the occurrence
of an illness as an expected late-life stressor.28-29 Low ed-
ucational levels were associated with a higher frequen-
cy of depression. This was expected since having a high
educational level has been shown to be an important
contributor to enhanced personal internal resources.30
Regarding symptoms of depression, the severity of
COPD had a different role. More advanced disease was
associated with a higher frequency of symptoms of de-
pression. This might be explained by the role of physi-
cal functioning on symptoms of depression.31-32 Patients
with advanced COPD experience more physical disa-
bility. This was confirmed by the logistic regression
analysis, which identified patients’ functional mobility
as a predictor of clinically significant symptoms of de-
pression.
These findings suggest that many patients with
COPD suffer from symptoms of anxiety and depression
and thus interventions are needed to promote a healthy
adjustment to the disease. Pulmonary rehabilitation
programmes are recommended to improve the physi-
cal and psychological condition of patients with
COPD.33-34 According to recent international guidelines,
these programmes should include exercise training, 
education and behavioural change through collabora-
tive self-management interventions.33 In COPD and
other chronic diseases, there is evidence that these in-
terventions have a significant positive effect on patients’
emotional function.35-38 In Portugal, pulmonary reha-
bilitation programmes are scarce and typically com-
bine exercise training with education.39-40 Patients’ emo-
tional needs are not often directly addressed. It would
be logical to complement national programmes with
collaborative self-management interventions, since
they may increase instrumental and emotional coping
abilities to allow patients to manage the demands of the
disease. Collaborative self-management interventions
place patients and health professionals in partnership
to enhance patients’ self-efficacy and self-management
abilities.33 It remains to be determined if involving the
family caregiver in this partnership brings additional
benefits to patients.
This study has some limitations. Possible sources of
bias were the recruitment strategy using clinicians in
the institutions involved and the fact that the sample
was recruited from only the central region of Portugal.
Future studies containing a larger sample and inclu-
ding patients with COPD from other regions of the
country would be more representative of the Por-
tuguese population with COPD. A control group of
healthy individuals with similar socio-demographic
characteristics should also be included in further re-
search to increase the validity of these findings. The use
of HADS to assess symptoms of anxiety and depression
may have introduced a bias in the study since some au-
thors have recently emphasised that the assumed bi-di-
mensionality of the HADS may not be appropriate.41-42
However, this instrument was used as a screening tool
for symptoms of anxiety and depression and not as an
instrument for diagnosis of clinical anxiety or depres-
sion. The HADS has shown to be a reliable instrument
internationally for measuring emotional distress of pa-
tients with COPD. This study focused on the presence
of clinically significant symptoms of anxiety and de-
pression (i.e., HADS-A/HADS-D≥8). It may be interes-
ting to explore the absolute scores of HADS-A and
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HADS-D and derive predictive equations. Another lim-
itation of the present study is related to its cross-sec-
tional nature. The frequency of distressing symptoms
and the relationships with associated factors could not
be established along the progression of the disease.
Longitudinal studies following a cohort of patients with
COPD would address this issue and identify other pre-
dictors of symptoms of anxiety and depression. For ins-
tance, the predictive value of alexithymia could be in-
vestigated. Recent research found a strong association
between this condition and distressing symptoms in
patients with COPD.43
CONCLUSION
A large proportion of Portuguese patients with COPD
experience symptoms of anxiety and depression. Limi-
tation of activities resulting from breathlessness, female
gender, age, and functional mobility were predictors of
these distressing symptoms. To address patients’ emo-
tional needs, national pulmonary rehabilitation pro-
grammes should include a collaborative self-manage-
ment component. Future research could explore the 
effects of involving family caregivers in these interven-
tions on beneficial outcomes for patients.
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RESUMO
ANSIEDADE E DEPRESSÃO EM PACIENTES PORTUGUESES COM DOENÇA PULMONAR OBSTRUTIVA CRÓNICA:
UM ESTUDO MULTICÊNTRICO, TRANSVERSAL
Objetivos:Avaliar sintomas de ansiedade e depressão em pacientes Portugueses com doença pulmonar obstrutiva crónica (DPOC)
e fatores preditores associados.
Tipo de estudo: Estudo multicêntrico, transversal.
Local: Três centros de saúde e um hospital distrital da região centro de Portugal.
População: 302 pacientes com DPOC.
Métodos: Os sintomas de ansiedade e depressão foram avaliados através da Escala de Ansiedade e Depressão (HADS). Pontu-
ações ≥8 foram consideradas clinicamente significativas.
Resultados: Esta amostra de pacientes tinham em média de 67±12 anos de idade e 41,1% era do género feminino. A DPOC
era de grau ligeiro em 106 (35,1%) pacientes, moderado em 106 (35,1%) e grave-a-muito-grave em 90 (29,8%). Sintomas de
ansiedade clinicamente significativos estavam presentes em 53,3% dos pacientes e sintomas de depressão em 45,4%. Os sin-
tomas de ansiedade estavam associados a limitação nas atividades (OR 1,39, 95% CI 1,04-1,84), idade (0,97, 95% CI 0,94-0,99)
e género feminino (OR 0,37; 95% CI 0,20-0,66). Os sintomas de depressão estavam associados à mobilidade funcional (OR
1,91, 95% CI 1,38-2,66) e a limitação nas atividades (OR 1,12, 95% CI 1,04-1,21).
Conclusão:Uma elevada proporção de pacientes com DPOC experiencia sintomas de ansiedade e depressão. Os programas na-
cionais de reabilitação respiratória deveriam incluir intervenções colaborativas de autogestão que respondam a estas necessi-
dades emocionais.
Palavras-chave: Doença Pulmonar Obstrutiva Crónica; Ansiedade; Depressão.
